MENU
OVID
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ovid Therapeutics (OVID) Ownership - Who owns Ovid Therapeutics?

Profile

Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
81.62M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.38
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

OVID
Capitalization
81.6M
P/E Ratio
N/A
Risk (Beta)
-0.38
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
0.92
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
43.4M
Shares Outstanding - Current
71M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
-64.286
View a ticker or compare two or three
OVID
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Provides medicines to children and adults with neurological disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com